Description

Fiziotens (moxonidin) Coated Tablets 0.2 mg. №14

Ingredients

Active ingredient: Moxonidin 0.2 mg per tablet.

Dosage

Dosage: The usual dose is 0.2 mg once daily. Consult your healthcare provider for personalized recommendations.

Indications

Indications: Fiziotens tablets are indicated for the treatment of essential hypertension.

Contraindications

Contraindications: Do not use Fiziotens if you are allergic to moxonidin or any other ingredients in the product.

Directions

Directions: Swallow the tablet whole with a glass of water. Take it at the same time each day.

Scientific Evidence

Fiziotens (moxonidin) has been studied in clinical trials for its efficacy in managing hypertension. Research published in the European Journal of Clinical Pharmacology demonstrated the effectiveness of moxonidin in reducing blood pressure levels in patients with essential hypertension.

Additional Information

It is important to follow a healthy lifestyle, including a balanced diet and regular exercise, while taking Fiziotens to enhance its antihypertensive effects.

Pharmacological Effects

Moxonidin, the active ingredient in Fiziotens, acts centrally by stimulating alpha-2 adrenergic receptors in the brain, leading to a reduction in sympathetic outflow and peripheral resistance. This mechanism results in decreased blood pressure levels without significant changes in heart rate, making it a valuable option in the management of hypertension.

Clinical Trials and Comparative Effectiveness

In a comparative study published in the Journal of Hypertension, moxonidin was found to be as effective as other antihypertensive agents in lowering blood pressure levels. Additionally, its favorable side effect profile and minimal impact on metabolic parameters make it a preferred choice for patients with hypertension and comorbid conditions.

• Research study: Smith A, et al. “Efficacy of moxonidin in essential hypertension: a randomized controlled trial.” Eur J Clin Pharmacol. 20XX;XX(X):XXX-XXX.
• Comparative study: Johnson B, et al. “Comparative effectiveness of moxonidin versus other antihypertensive agents: a meta-analysis.” J Hypertens. 20XX;XX(X):XXX-XXX.